Your browser doesn't support javascript.
loading
A Phase I Trial to Evaluate Antibody-Dependent Cellular Cytotoxicity of Cetuximab and Lenalidomide in Advanced Colorectal and Head and Neck Cancer.
Bertino, Erin M; McMichael, Elizabeth L; Mo, Xiaokui; Trikha, Prashant; Davis, Melanie; Paul, Bonnie; Grever, Michael; Carson, William E; Otterson, Gregory A.
Afiliación
  • Bertino EM; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio. erin.bertino@osumc.edu.
  • McMichael EL; Biomedical Sciences Graduate Program, College of Medicine, The Ohio State University, Columbus, Ohio.
  • Mo X; Center for Biostatistics, The Ohio State University, Columbus, Ohio.
  • Trikha P; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Davis M; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Paul B; Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.
  • Grever M; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
  • Carson WE; Division of Surgical Oncology, Department of Surgery, The Ohio State University, Columbus, Ohio. Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, Ohio.
  • Otterson GA; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus, Ohio.
Mol Cancer Ther ; 15(9): 2244-50, 2016 09.
Article en En | MEDLINE | ID: mdl-27458141

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Cetuximab / Neoplasias de Cabeza y Cuello / Citotoxicidad Celular Dependiente de Anticuerpos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2016 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Protocolos de Quimioterapia Combinada Antineoplásica / Cetuximab / Neoplasias de Cabeza y Cuello / Citotoxicidad Celular Dependiente de Anticuerpos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2016 Tipo del documento: Article